Changes following supplementation with lutein and zeaxanthin in retinal function in eyes with early age-related macular degeneration: A randomised, double-blind, placebo-controlled trial

British Journal of Ophthalmology

Volumn 99, Issue 3, 2015, Pages 371-375

  Huang, Yang Mu ^a   Dou, Hong Liang ^b   Huang, Fei Fei ^a   Xu, Xian Rong ^a   Zou, Zhi Yong ^a   Lu, Xin Rong ^b   Lin, Xiao Ming ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b PEKING UNIVERSITY THIRD HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; XANTHOPHYLL; ZEAXANTHIN; DRUG COMBINATION; VISUAL PIGMENT;

AGE RELATED MACULAR DEGENERATION; AGED; ARTICLE; CHINA; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ELECTRORETINOGRAM; FEMALE; HUMAN; MACULAR PIGMENT OPTICAL DENSITY; MAJOR CLINICAL STUDY; MALE; OPTICAL DENSITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETINA; SENSITIVITY ANALYSIS; VISUAL SYSTEM FUNCTION; DIET SUPPLEMENTATION; DRUG COMBINATION; ELECTRORETINOGRAPHY; MACULAR DEGENERATION; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PERIMETRY; PHYSIOLOGY; QUESTIONNAIRE; VISUAL FIELD;

AGED; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; ELECTRORETINOGRAPHY; FEMALE; HUMANS; LUTEIN; MACULAR DEGENERATION; MACULAR PIGMENT; MALE; MIDDLE AGED; QUESTIONNAIRES; RETINA; VISUAL FIELD TESTS; VISUAL FIELDS; ZEAXANTHINS;

EID: 84923221616     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2014-305503     Document Type: Article

References (25)

1. Ding X, Patel M, Chan CC. Molecular pathology of age-related macular degeneration. Prog Retin Eye Res 2009;28:1-18.
2. Coleman HR, Chan CC, Ferris FR, et al. Age-related macular degeneration. Lancet 2008;372:1835-45.
3. Lim LS, Mitchell P, Seddon JM, et al. Age-related macular degeneration. Lancet 2012;379:1728-38.
4. Krinsky NI, Landrum JT, Bone RA. Biologic mechanisms of the protective role of lutein and zeaxanthin in the eye. Annu Rev Nutr 2003;23:171-201.
5. Moeller SM, Parekh N, Tinker L, et al . Associations between intermediate age-related macular degeneration and lutein and zeaxanthin in the Carotenoids in Age-related Eye Disease Study (CAREDS): ancillary study of the Women's Health Initiative. Arch Ophthalmol 2006;124:1151-62.
6. Tan JS, Wang JJ, Flood V, et al. Dietary antioxidants and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study. Ophthalmology 2008;115:334-41.
7. Richer SP, Stiles W, Graham-Hoffman K, et al. Randomized, double-blind, placebo-controlled study of zeaxanthin and visual function in patients with atrophic age-related macular degeneration: the Zeaxanthin and Visual Function Study (ZVF) FDA IND #78, 973. Optometry 2011;82:667-80.
8. Weigert G, Kaya S, Pemp B, et al. Effects of lutein supplementation on macular pigment optical density and visual acuity in patients with age-related macular degeneration. Invest Ophthalmol Vis Sci 2011;52:8174-8.
9. Sabour-Pickett S, Beatty S, Connolly E, et al. Supplementation with three different macular carotenoid formulations in patients with early age-related macular degeneration. Retina 2014;34:1757-66.
10. Murray IJ, Makridaki M, van der Veen RL, et al. Lutein supplementation over a one-year period in early AMD might have a mild beneficial effect on visual acuity: the CLEAR study. Invest Ophthalmol Vis Sci 2013;54:1781-8.
11. The Age-Related Eye Disease Study 2 (AREDS2) Research Group. Lutein+zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA 2013;309:2005-15.
12. Klein R, Klein BE, Jensen SC, et al. The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 1997;104:7-21.
13. Ma L, Dou HL, Huang YM, et al. Improvement of retinal function in early age-related macular degeneration after lutein and zeaxanthin supplementation: a randomized, double-masked, placebo-controlled trial. Am J Ophthalmol 2012;154:625-34.
14. Woo JH, Sanjay S, Au EK. Benefits of early awareness in age-related macular degeneration. Eye (Lond) 2009;23:2271; author reply 2271-2.
15. Davis MD, Gangnon RE, Lee LY, et al. The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17. Arch Ophthalmol 2005;123:1484-98.
16. Ma L, Yan SF, Huang YM, et al. Effect of lutein and zeaxanthin on macular pigment and visual function in patients with early age-related macular degeneration. Ophthalmology 2012;119:2290-7.
17. Richer S, Stiles W, Statkute L, et al. Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial). Optometry 2004;75:216-30.
18. Trieschmann M, Beatty S, Nolan JM, et al. Changes in macular pigment optical density and serum concentrations of its constituent carotenoids following supplemental lutein and zeaxanthin: the LUNA study. Exp Eye Res 2007;84:718-28.
19. Parisi V, Tedeschi M, Gallinaro G, et al. Carotenoids and antioxidants in age-related maculopathy Italian study: multifocal electroretinogram modifications after 1 year. Ophthalmology 2008;115:324-33.
20. Johnson EJ, Neuringer M, Russell RM, et al. Nutritional manipulation of primate retinas, III: Effects of lutein or zeaxanthin supplementation on adipose tissue and retina of xanthophyll-free monkeys. Invest Ophthalmol Vis Sci 2005;46:692-702.
21. Li B, Ahmed F, Bernstein PS. Studies on the singlet oxygen scavenging mechanism of human macular pigment. Arch Biochem Biophys 2010;504:56-60.
22. Loughman J, Nolan JM, Howard AN, et al. The impact of macular pigment augmentation on visual performance using different carotenoid formulations. Invest Ophthalmol Vis Sci 2012;53:7871-80.
23. Connolly EE, Beatty S, Thurnham DI, et al. Augmentation of macular pigment following supplementation with all three macular carotenoids: an exploratory study. Curr Eye Res 2010;35:335-51.
24. Parravano M, Oddone F, Tedeschi M, et al. Retinal functional changes measured by microperimetry in neovascular age-related macular degeneration treated with ranibizumab: 24-month results. Retina 2010;30:1017-24.
25. Wooten BR, Hammond BR. Macular pigment: influences on visual acuity and visibility. Prog Retin Eye Res 2002;21:225-40.